NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neela Cell Therapeutics

Neela Cell Therapeutics

Private
Athens, GeorgiaHealthcare & Life Scienceshttps://neelacelltx.com/

Last Round

Convertible Debt

Nov 24, 2025

Total Funding Raised

$13.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neela Cell Therapeutics is a biotechnology company developing genipin as a treatment for peripheral neuropathy and producing peripheral neurons from human pluripotent stem cells for research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peripheral neuropathygenipinperipheral neuronsnerve regenerationhuman pluripotent stem cellshPSCdrug discovery toolsdisease-modifying treatmentstem cell linescell modelsdisease modelingneurotherapeuticsbiotechpre-clinical development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neela Cell Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Neela Cell Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neela Cell Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtNov 24, 2025
GrantJun 1, 2025

Neela Cell Therapeutics Investors

Notable investors and investment history

Neela Cell Therapeutics investors
InvestorRounds
Georgia Research AllianceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 24, 2025

    $14M round led by Biogen.

  • Jun 1, 2025

    $50K grant received from Georgia Research Alliance.

Neela Cell Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neela Cell Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neela Cell Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAthens, Georgia
Year Founded2024
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.